Podcast Summary: Stuff You Should Know – "How Antidepressants Work"
Release Date: March 13, 2025
Hosts: Josh Clark and Chuck Bryant
Produced by: iHeartPodcasts
Introduction: Addressing the Overlooked Topic of Depression
In this insightful episode of Stuff You Should Know, hosts Josh Clark and Chuck Bryant delve into the complex world of antidepressants—a topic they realized they had yet to explore in depth. Recognizing the widespread impact of depression, they aim to educate listeners on how these medications work, their various types, and the broader context of treating depression.
Understanding Depression
Prevalence and Definitions
Josh begins by highlighting the staggering statistics surrounding depression. "I saw something like 60 million adults in America, and I think they define that over age 18 these days for this kind of stuff, have some sort of diagnosed depression" (02:28). Among these, approximately 20 million grapple with Major Depressive Disorder (MDD), also known as clinical or unipolar depression, distinct from bipolar disorder which includes both manic and depressive episodes.
Symptoms and Impact
Chuck elaborates on the debilitating symptoms of depression: persistent sadness, disrupted sleep, feelings of worthlessness, impaired concentration, and anhedonia—the inability to experience pleasure. "It's a persistent thing where it disrupts your life, it interferes with your life, it can interfere with your relationships and interfere with your relationship with yourself in a big, big way" (03:56).
The Biological Model: How Antidepressants Work
Neurotransmitter Imbalance
Josh introduces the biological model as the foundation for modern antidepressant treatment. "Ever since the '70s, people have kind of basically treated depression based on what's called the biological model. And the biological model says that you're depressed because there's an imbalance of neurotransmitters, chemicals in your brain, and usually they zero in on serotonin" (07:40).
Challenging the Premise
However, Chuck points out the complexities and uncertainties within this model. "We don't know the underlying mechanism that actually causes it. And because that we don't exactly know how antidepressants work... we just know it works" (08:53). This underscores the ongoing research and debate in the field.
Classes of Antidepressants
1. Selective Serotonin Reuptake Inhibitors (SSRIs)
Introduction and Examples
Josh and Chuck discuss SSRIs as the cornerstone of modern antidepressant therapy. "SSRIs are basically the flagship antidepressant, if there is such a thing" (19:13). Examples include:
- Fluoxetine (Prozac)
- Paroxetine (Paxil)
- Sertraline (Zoloft)
- Fluvoxamine (Luvox)
- Citalopram (Celexa)
- Escitalopram (Lexapro)
Mechanism of Action
Chuck explains, "They're gonna block that bus trip that serotonin takes back to that original cell... and it leaves it floating around in that space in between" (17:28). By inhibiting the reuptake of serotonin, SSRIs increase its availability in the synaptic cleft, enhancing mood.
Advantages and Side Effects
SSRIs are favored for their efficacy and relatively fewer side effects. Josh notes, "they work really, really, really well on most people with the fewest side effects." However, potential side effects include anxiety, sexual dysfunction, and vertigo (20:29).
2. Tricyclic Antidepressants (TCAs)
Historical Context and Examples
Chuck takes listeners back to the 1950s and '60s, discussing TCAs like Nortriptyline and Amitriptyline. "They were easier to overdose on and you're just not gonna see them a lot for depression these days" (25:09).
Mechanism and Challenges
Unlike SSRIs, TCAs are non-selective, affecting multiple neurotransmitters, which leads to a higher incidence of side effects. This lack of specificity made them less desirable compared to newer medications.
3. Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Introduction and Examples
Emerging in the mid-1990s, SNRIs like Venlafaxine (Effexor) and Duloxetine (Cymbalta) target both serotonin and norepinephrine. "They're basically just as good as the SSRIs... they have about the same number of side effects, too" (26:55).
Efficacy and Side Effects
While SNRIs offer an alternative for those who might not respond to SSRIs, they don't significantly outperform them in terms of effectiveness and come with a similar side effect profile.
4. Monoamine Oxidase Inhibitors (MAOIs)
Historical Discovery and Risks
Josh introduces MAOIs, explaining their accidental discovery in the 1950s. These inhibitors prevent the breakdown of monoamines, including tyramine, leading to the infamous "cheese reaction"—a hypertensive crisis triggered by consuming tyramine-rich foods like aged cheese (30:07).
Current Use and Limitations
Due to dietary restrictions and potential severe side effects, MAOIs are rarely prescribed today and are typically reserved for cases resistant to other treatments.
Alternative Treatments: Nutraceuticals and Psychedelics
Nutraceuticals: Supplements as Antidepressants
Josh discusses the rise of nutraceuticals—over-the-counter supplements touted for treating depression. While some, like St. John's Wort, have historical usage and supporting studies, the lack of regulation in the U.S. poses significant risks. "There's no one checking out, like, to make sure that the dose is the same pill to pill" (33:48).
Risks and Efficacy
Supplement quality varies, and interactions with other medications can lead to adverse effects. Josh emphasizes the importance of caution: "St. John's Wort reduces the effectiveness of... birth control pills" (35:58).
Psychedelics: The Emerging Frontier
Chuck and Josh explore the potential of psychedelics like ketamine and psilocybin in treating depression. Recent studies show remarkable efficacy, with psilocybin demonstrating long-lasting effects after just a couple of doses. "After a year from the second dose, they... the effects were like, just mind blowing" (40:50).
Clinical Approval and Future Prospects
Esketamine, a derivative of ketamine, received FDA approval in 2019 as a breakthrough treatment. Meanwhile, psilocybin continues to gain traction through ongoing research, promising transformative results for those with treatment-resistant depression.
Treatment Phases and Prescription Trends
Phased Approach to Treatment
Josh outlines the typical treatment trajectory for depression:
- Acute Phase: Immediate intervention with antidepressants to alleviate severe symptoms.
- Continuation Phase: Stabilizing and eliminating remaining symptoms over six months.
- Maintenance Phase: Ongoing treatment to prevent relapse, often lasting indefinitely.
"Once they find an antidepressant that can manage your symptoms, you'll move into what's called the continuation phase" (42:49).
Increasing Prescription Rates
Chuck addresses concerns about the rising number of antidepressant prescriptions, particularly among young people. "In the United States, people ages 12 to 25, between 2016 and 2022, monthly prescriptions of antidepressants went up 66%" (45:47). Factors include heightened stress levels from global events like the COVID-19 pandemic and reduced stigma surrounding mental health care.
Potential Adverse Effects: When Antidepressants May Worsen Depression
Possible Reasons for Deterioration
While antidepressants are generally effective, some individuals may experience worsening symptoms due to:
- Misdiagnosis: Conditions like bipolar disorder or borderline personality disorder may be incorrectly treated with antidepressants.
- Genetic Factors: Variations in genes like SLC64A can affect individual responses, sometimes making symptoms worse (48:45).
- Side Effects: Issues like akathisia (internal restlessness) and interactions from polypharmacy can exacerbate depression (49:02).
Importance of Medical Oversight
Josh emphasizes the necessity of working closely with healthcare providers to tailor treatments and monitor responses, ensuring that antidepressants are both safe and effective for each individual.
Listener Mail: Exploring Hypnagogic Imagery
Towards the episode's end, Josh and Chuck share a listener's experience with hypnagogic imagery—the vivid, often nonsensical thoughts and hallucinations that occur as one falls asleep. This segment highlights the podcast's dedication to addressing a wide range of mental experiences and offering relatable insights.
Conclusion: Encouraging Open Dialogue and Seeking Help
Both hosts reiterate the importance of recognizing depression as a treatable condition. "If you have depression and you're not treating it, there's definitely hope" (04:51). They encourage listeners to seek professional help and stay informed about the various treatment options available, whether pharmaceutical or alternative.
For more insightful episodes, visit the iHeartRadio app or wherever you listen to your favorite podcasts.